WO2024010355A1 - Composition antivieillissement contenant un extrait de lie de vin de gosori - Google Patents
Composition antivieillissement contenant un extrait de lie de vin de gosori Download PDFInfo
- Publication number
- WO2024010355A1 WO2024010355A1 PCT/KR2023/009485 KR2023009485W WO2024010355A1 WO 2024010355 A1 WO2024010355 A1 WO 2024010355A1 KR 2023009485 W KR2023009485 W KR 2023009485W WO 2024010355 A1 WO2024010355 A1 WO 2024010355A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- aging
- skin
- gosori
- sake lees
- extract
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 50
- 230000003712 anti-aging effect Effects 0.000 title claims abstract description 32
- 239000002537 cosmetic Substances 0.000 claims abstract description 29
- 230000001737 promoting effect Effects 0.000 claims abstract description 28
- 230000002087 whitening effect Effects 0.000 claims abstract description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 239000004480 active ingredient Substances 0.000 claims description 17
- 244000062793 Sorghum vulgare Species 0.000 claims description 16
- 235000019713 millet Nutrition 0.000 claims description 16
- 235000007164 Oryza sativa Nutrition 0.000 claims description 14
- 235000009566 rice Nutrition 0.000 claims description 14
- 230000032683 aging Effects 0.000 claims description 12
- 230000037303 wrinkles Effects 0.000 claims description 11
- 239000006071 cream Substances 0.000 claims description 9
- 239000006210 lotion Substances 0.000 claims description 9
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 8
- 238000009835 boiling Methods 0.000 claims description 8
- 230000037394 skin elasticity Effects 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims description 5
- 239000000839 emulsion Substances 0.000 claims description 5
- 230000036560 skin regeneration Effects 0.000 claims description 5
- 201000004624 Dermatitis Diseases 0.000 claims description 4
- 239000000499 gel Substances 0.000 claims description 4
- 238000004898 kneading Methods 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 3
- 239000006072 paste Substances 0.000 claims description 3
- 239000004094 surface-active agent Substances 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- 239000000344 soap Substances 0.000 claims description 2
- 240000007594 Oryza sativa Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 52
- 230000028327 secretion Effects 0.000 abstract description 35
- 210000002374 sebum Anatomy 0.000 abstract description 26
- 108010035532 Collagen Proteins 0.000 abstract description 24
- 102000008186 Collagen Human genes 0.000 abstract description 24
- 229920001436 collagen Polymers 0.000 abstract description 24
- 102000016387 Pancreatic elastase Human genes 0.000 abstract description 22
- 108010067372 Pancreatic elastase Proteins 0.000 abstract description 22
- 239000000126 substance Substances 0.000 abstract description 22
- 230000015572 biosynthetic process Effects 0.000 abstract description 19
- 238000003786 synthesis reaction Methods 0.000 abstract description 19
- 230000032677 cell aging Effects 0.000 abstract description 15
- 230000002401 inhibitory effect Effects 0.000 abstract description 15
- 230000036542 oxidative stress Effects 0.000 abstract description 13
- 230000009759 skin aging Effects 0.000 abstract description 13
- 230000002757 inflammatory effect Effects 0.000 abstract description 12
- 206010040880 Skin irritation Diseases 0.000 abstract description 10
- 238000004519 manufacturing process Methods 0.000 abstract description 10
- 230000036556 skin irritation Effects 0.000 abstract description 10
- 231100000475 skin irritation Toxicity 0.000 abstract description 10
- 230000002265 prevention Effects 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 50
- 210000004027 cell Anatomy 0.000 description 24
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 18
- 239000004615 ingredient Substances 0.000 description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 14
- 241000209094 Oryza Species 0.000 description 14
- 210000002950 fibroblast Anatomy 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 13
- 238000000605 extraction Methods 0.000 description 12
- 238000012360 testing method Methods 0.000 description 11
- 238000009472 formulation Methods 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 230000001965 increasing effect Effects 0.000 description 9
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 8
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 8
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 239000012091 fetal bovine serum Substances 0.000 description 8
- 230000006872 improvement Effects 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 8
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 7
- 230000007423 decrease Effects 0.000 description 7
- 238000000855 fermentation Methods 0.000 description 7
- 230000004151 fermentation Effects 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 7
- 210000002540 macrophage Anatomy 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 230000010094 cellular senescence Effects 0.000 description 6
- 238000012790 confirmation Methods 0.000 description 6
- 239000012228 culture supernatant Substances 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- -1 fatty acid esters Chemical class 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 230000008099 melanin synthesis Effects 0.000 description 6
- 210000002752 melanocyte Anatomy 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 239000013641 positive control Substances 0.000 description 6
- 238000004113 cell culture Methods 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000049 pigment Substances 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- 238000002137 ultrasound extraction Methods 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 4
- 101800003838 Epidermal growth factor Proteins 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 229940116977 epidermal growth factor Drugs 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000028709 inflammatory response Effects 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 235000019997 soju Nutrition 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 4
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 3
- VOUAQYXWVJDEQY-QENPJCQMSA-N 33017-11-7 Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 VOUAQYXWVJDEQY-QENPJCQMSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000228212 Aspergillus Species 0.000 description 3
- 108010075254 C-Peptide Proteins 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 235000005135 Micromeria juliana Nutrition 0.000 description 3
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- 241000246354 Satureja Species 0.000 description 3
- 235000007315 Satureja hortensis Nutrition 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- ITBPIKUGMIZTJR-UHFFFAOYSA-N [bis(hydroxymethyl)amino]methanol Chemical compound OCN(CO)CO ITBPIKUGMIZTJR-UHFFFAOYSA-N 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000004207 dermis Anatomy 0.000 description 3
- 229910052571 earthenware Inorganic materials 0.000 description 3
- 239000002158 endotoxin Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 229920006008 lipopolysaccharide Polymers 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 3
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 3
- 229940113124 polysorbate 60 Drugs 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 3
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 3
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 206010033733 Papule Diseases 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 108010050808 Procollagen Proteins 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000012979 RPMI medium Substances 0.000 description 2
- 241000235070 Saccharomyces Species 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 2
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 210000004177 elastic tissue Anatomy 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 231100000344 non-irritating Toxicity 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 229930014124 (-)-epigallocatechin gallate Natural products 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 108090000672 Annexin A5 Proteins 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 238000011891 EIA kit Methods 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 102000009465 Growth Factor Receptors Human genes 0.000 description 1
- 108010009202 Growth Factor Receptors Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 206010039796 Seborrhoeic keratosis Diseases 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 206010064127 Solar lentigo Diseases 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- CJPQIRJHIZUAQP-MRXNPFEDSA-N benalaxyl-M Chemical compound CC=1C=CC=C(C)C=1N([C@H](C)C(=O)OC)C(=O)CC1=CC=CC=C1 CJPQIRJHIZUAQP-MRXNPFEDSA-N 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000005786 degenerative changes Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 231100000067 mild irritant Toxicity 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- VOFUROIFQGPCGE-UHFFFAOYSA-N nile red Chemical compound C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4OC3=CC(=O)C2=C1 VOFUROIFQGPCGE-UHFFFAOYSA-N 0.000 description 1
- HLNRBHDRGMNBEG-UHFFFAOYSA-N nitrous acid Chemical compound ON=O.ON=O HLNRBHDRGMNBEG-UHFFFAOYSA-N 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 210000004378 sebocyte Anatomy 0.000 description 1
- 201000003385 seborrheic keratosis Diseases 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000002602 strong irritant Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 210000005167 vascular cell Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Definitions
- the present invention relates to an anti-aging composition containing an extract of Gosori sake sake lees. More specifically, the present invention is a sake lees extract that improves skin aging through the effect of suppressing cellular aging caused by oxidative stress, promoting collagen synthesis, suppressing elastase activity, suppressing secretion of inflammatory substances, promoting sebum secretion, and whitening effect. It relates to an anti-aging composition containing as an active ingredient.
- Aging causes disharmony in the skin's immune system, which causes various skin diseases.
- the skin is the organ where aging primarily occurs, and much research has been conducted in the cosmetics field to delay or prevent it.
- skin aging begins to progress around the age of 25 and progresses in earnest around the age of 40.
- Skin aging is divided into extrinsic aging and intrinsic aging.
- Intrinsic aging is a natural phenomenon caused by degenerative changes that occur in proportion to the progression of time as one ages. Changes in the external appearance of the skin related to skin aging include dry skin, sagging skin, and wrinkles due to decreased moisture and sebum secretion, and skin diseases include seborrheic keratosis and sunspots.
- the representative trigger of extrinsic aging is reactive oxygen species, which are generated from ultraviolet rays, pollution, inflammation, and the cell's own metabolic process, and act to promote cellular aging.
- Gosorisul is a traditional Jeju liquor and is also called Omegisul.
- “Omegi rice cake” is made by kneading millet alone or with rice, boiling it in water, and going through a fermentation process using malt or yeast. Afterwards, soju is distilled using a gosori, an earthenware vessel for boiling soju, and the remaining dregs become sake lees. In the case of this type of sake lees, it was a discarded resource as a brewing by-product, and little research on its physiological activity has been conducted so far.
- the present inventors continued research to develop a natural anti-aging composition with high stability and safety and no skin side effects.
- the results showed that the sake lees extract from Gosori Sul has an effect of suppressing cellular aging caused by oxidative stress, promoting collagen synthesis, By discovering that it can simultaneously exhibit an elastase activity inhibition effect, an inflammatory substance secretion inhibition effect, a sebum secretion promotion effect, and a whitening effect, it was discovered that it is a useful ingredient for anti-aging, and the present invention was completed.
- One object of the present invention is to provide an anti-aging composition containing sake lees extract from Gosori Sul as an active ingredient.
- Another object of the present invention is to provide a cosmetic composition containing the anti-aging composition.
- Another object of the present invention is to provide a method for preventing or improving skin aging using the composition.
- the present invention relates to an anti-aging composition containing sake lees extract from Gosori Sul as an active ingredient. More specifically, the present invention relates to a cosmetic composition containing sake lees extract from Gosori Sul as an active ingredient.
- the composition is free from skin irritation and cytotoxicity and has excellent human safety, while suppressing cellular aging caused by oxidative stress. , It can improve skin aging by promoting collagen synthesis, suppressing elastase activity, suppressing secretion of inflammatory substances, promoting sebum secretion, and effectively suppressing melanin production.
- the present invention provides an anti-aging composition containing an extract of sake lees from Gosori Sul as an active ingredient.
- Gosori alcohol of the present invention is a traditional liquor of Jeju Island, mixed with millet and rice, kneaded, boiled in boiling water, fermented using malt and yeast, and then distilled in Gosori, an earthenware vessel for boiling soju.
- the Gosori liquor unlike traditional liquor in other regions, is characterized by mixing millet and rice, kneading and fermenting.
- the mixture of millet and rice is at a weight ratio of 1:9 to 9:1, preferably 2:8 to 8:2, more preferably 3:7 to 7:3, even more preferably 5. It can be achieved with a weight ratio of :5.
- the millet is the grain remaining after removing the fruit of the millet. It is rich in protein, second only to soybeans among grains, contains more unsaturated fatty acids than rice or barley, contains carotene that is not found in ordinary grains, and has a savory taste.
- the rice is the remaining grains after removing the fruit of the rice plant, and unlike the millet, it contains a lot of starch.
- the content of the millet is less than the above range, the sensory properties (particularly the savory taste) due to the content of the millet are reduced, which not only poses a problem in the sensory quality of the high-soured liquor produced, but also the useful content contained in the millet reduces the high-sourized liquor. There is a problem in that very little remains in the sake lees, making the effects described below very weak.
- the content of millet exceeds the above range, there is an advantage that the sensory quality of gosori liquor produced is improved due to the increase in savory taste due to the inclusion of millet, and the above-mentioned useful components contained in millet are used as sake lees of gosori liquor.
- the effect described below is excellent because a large amount remains in the rice, but there is a problem that the quality of Gosori liquor is reduced because the rice content is relatively reduced and fermentation does not occur sufficiently.
- the yeast is preferably a fermenting microorganism of the genus Aspergillus ( Aspergillus spp.), and the yeast is preferably a fermenting microorganism of the genus Saccharomyces ( Sacchraromycess spp.).
- the sake lees of the high-sori liquor of the present invention is the liquor residue remaining after producing the high-sori liquor.
- the “sake lees extract of Gosori liquor” is extracted from the sake lees of Gosori liquor, and the “extract” is obtained by immersing the target substance in various solvents and then extracting it at room temperature or at a heated state for a certain period of time. It refers to the results such as the liquid component obtained by fractionation and the solid component obtained by removing the solvent from the liquid component. In addition, in addition to the above results, it can be comprehensively interpreted to include all dilutions of the results, concentrates thereof, crude preparations, purifications, etc. of the above results.
- extract of the highly fermented liquor of the present invention can be extracted using a conventional solvent known in the art, and the extracted liquid can be used in liquid form or after being concentrated and/or dried.
- the solvent used is water, anhydrous or hydrous lower alcohol having 1 to 4 carbon atoms (methanol, ethanol, propanol, butanol, etc.), a mixed solvent of the lower alcohol and water, acetone, ethyl acetate, chloroform, or 1,3- Any solvent of butylene glycol can be used.
- extraction may be performed using methanol, ethanol, or butanol.
- the degree of extraction and loss of the active ingredients of the extract may vary depending on the organic solvent used for extraction, so it is desirable to select and use an appropriate organic solvent.
- the extraction method is not particularly limited to this, but includes cold needle extraction, ultrasonic extraction, or reflux cooling extraction, and is preferably performed using the ultrasonic extraction method.
- the sake lees extract from the high-steaming liquor can be obtained through a conventional purification process in addition to extraction using the extraction solvent.
- various additional purification methods such as separation using ultrafiltration membranes with a certain molecular weight cut-off value, separation by various chromatographs (designed for separation according to size, charge, hydrophobicity, or affinity).
- Sake lees extract can also be obtained through the obtained fraction.
- the sake lees of Gosori sake are shaded and ground, then 0.5 to 20 times the weight of the dried sample, preferably 1 to 15 times the amount of water, C1 to C4 lower alcohol such as ethanol, methanol, etc.
- a mixed solvent of water and ethanol at room temperature for about 20 to 70 hours, preferably 40 to 50 hours, using extraction methods such as stirred extraction, hot water extraction, cold immersion extraction, reflux cooling extraction, or ultrasonic extraction.
- the extract obtained after ultrasonic extraction can be filtered, concentrated under reduced pressure, or dried to obtain a sake lees extract.
- the “anti-aging” refers to reducing or preventing aging or death of skin cells or damage caused by external pressure, fine or coarse wrinkles, decreased skin elasticity, etc., through cell aging inhibition, prevention, and regenerative effects. Or it means improving. Therefore, “anti-aging” in the present invention includes preventing or improving skin wrinkles, preventing or improving skin elasticity, promoting skin regeneration, preventing, reducing, or improving skin inflammation, and preventing or improving skin whitening. can be considered. Additionally, the term “anti-aging” may be used interchangeably with aging improvement or skin aging improvement in this specification.
- the Gosori liquor sake lees extract of the present invention has an effect of suppressing cellular aging caused by oxidative stress, an effect of promoting collagen synthesis, an effect of suppressing elastase activity, an effect of suppressing secretion of inflammatory substances, an effect of promoting sebum secretion, and a whitening effect. It is very useful in preventing, improving and treating skin aging.
- prevention refers to suppressing or minimizing cell aging caused by oxidative stress, suppressing or minimizing skin wrinkles by promoting the synthesis of skin collagen, suppressing the activity of elastase, and promoting sebum secretion. , increases skin elasticity by promoting the synthesis of skin collagen, suppressing the activity of elastase, and promoting sebum secretion, increases anti-inflammation of the skin by suppressing or reducing the secretion of inflammatory substances, or increases the production of melanin. It refers to suppressing and minimizing skin aging by increasing skin whitening.
- the term “improvement” or “treatment” refers to suppressing or minimizing cell aging caused by oxidative stress, or reducing skin wrinkles by promoting the synthesis of skin collagen, suppressing the activity of elastase, and promoting sebum secretion. Inhibit or minimize, increase skin elasticity by promoting the synthesis of skin collagen, suppressing the activity of elastase, and promoting sebum secretion, or increasing anti-inflammation of the skin by suppressing or reducing the secretion of inflammatory substances, It refers to preventing skin aging and returning the skin condition to its previous state by increasing the production of melanin and increasing skin whitening.
- the cells include all cells existing in vivo or cultured in vitro .
- the cells can be classified in various ways based on cell shape and location, and examples include skin cells (epidermis, dermis, dermal papilla cells, melanin, etc.), fibroblasts, adipocytes, stem cells, and vascular cells. .
- cellular senescence was induced in human fibroblasts and the degree of cellular senescence was examined depending on the concentration of the high-solid sake lees extract of the present invention. As a result, as the concentration of the highly-sulliary sake lees extract increased, cellular senescence decreased. It was confirmed that the sake lees extract from Gosori Sul has an anti-aging effect (see Figure 1).
- an inflammatory response was induced in mouse macrophages and the degree of secretion of inflammatory substances (nitrite) according to the concentration of the sake lees extract of high-sori liquor was examined.
- nitrite nitrite
- the sake lees extract of high-sori liquor was secreted by the sake lees extract of high-sori liquor.
- production was found to be reduced, and it was confirmed that the sake lees extract from Gosori Sul has anti-inflammatory and anti-aging effects by suppressing the secretion of inflammatory substances (see Figure 4).
- the anti-aging composition containing the sake lees extract of Gosori sake of the present invention as an active ingredient contains 0.0001 to 20.0% by weight, preferably 0.001 to 10.0% by weight, of the sake lees extract of Gosori alcohol based on the total weight of the composition. . If the content of the sake lees extract of the Gosori liquor is less than 0.0001% by weight, anti-aging effect cannot be expected, and if it exceeds 20.0% by weight, the increase in anti-aging effect due to increase in content is minimal and difficulties arise in manufacturing the formulation. .
- the anti-aging composition of the present invention may be provided as an anti-aging cosmetic composition containing an extract of sake lees from Gosori Sul as an active ingredient.
- the cosmetic composition may preferably be in the form of a functional cosmetic, and the functionality may be skin anti-aging, including skin wrinkle improvement, skin antioxidant, skin anti-inflammatory, skin elasticity improvement, skin regeneration, skin whitening, etc.
- the sake lees extract of Gosori Sul is as described above, and the sake lees extract of Gosori Sul has skin anti-aging effects such as skin wrinkle improvement effect, skin antioxidant effect, skin elasticity enhancement effect, skin anti-inflammatory effect, and skin whitening effect. Because it has an effect, it can be usefully used as a cosmetic composition for skin anti-aging purposes such as improving skin wrinkles, skin antioxidant, improving skin elasticity, skin anti-inflammatory, skin regeneration, and skin whitening.
- the cosmetic composition may additionally contain ingredients commonly used in cosmetic compositions in addition to the sake lees extract of Gosori wine as an active ingredient with anti-aging effect.
- ingredients commonly used in cosmetic compositions in addition to the sake lees extract of Gosori wine as an active ingredient with anti-aging effect.
- it may include conventional auxiliaries and carriers such as antioxidants, stabilizers, solubilizers, vitamins, pigments and flavorings.
- the cosmetic composition can be manufactured in any formulation commonly manufactured in the art.
- it can be formulated as a solution, suspension, emulsion, paste, gel, cream, lotion, powder, soap, surfactant-containing cleansing, oil, powder foundation, emulsion foundation, wax foundation or spray.
- it can be manufactured in formulations such as nutritional cream, astringent lotion, softening lotion, lotion, essence, nutritional gel, or massage cream.
- it is not particularly limited thereto.
- the formulation of the cosmetic composition is a paste, cream or gel, animal oil, vegetable oil, wax, paraffin, starch, tragacanth, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide are used as carrier ingredients. It can be used.
- lactose When the formulation of the cosmetic composition is powder or spray, lactose, talc, silica, aluminum hydroxide, calcium silicate, or polyamide powder can be used as the carrier ingredient.
- chlorofluorohydrocarbon May contain propellants such as propane/butane or dimethyl ether.
- a solvent, solubilizing agent, or emulsifying agent may be used as a carrier component.
- a solvent, solubilizing agent, or emulsifying agent may be used as a carrier component.
- water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butyl glycol oil, glycerol aliphatic esters, polyethylene glycol or fatty acid esters of sorbitan can be used. there is.
- the carrier ingredients include water, a liquid diluent such as ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester, and polyoxyethylene sorbitan ester, and miso.
- a liquid diluent such as ethanol or propylene glycol
- a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester, and polyoxyethylene sorbitan ester
- miso Crystalline cellulose, aluminum metahydroxide, bentonite, agar, or tracant may be used.
- the carrier ingredients include aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyl taurate, sarcosinate, and fatty acid.
- Amide ether sulfate, alkylamidobetaine, fatty alcohol, fatty acid glyceride, fatty acid diethanolamide, vegetable oil, lanolin derivative, or ethoxylated glycerol fatty acid ester can be used.
- the cosmetic composition containing the sake lees extract of Gosori sake of the present invention as an active ingredient contains 0.0001 to 20.0% by weight, preferably 0.001 to 10.0% by weight, of the sake lees extract of Gosori alcohol based on the total weight of the composition. If the content of the sake lees extract of the Gosori liquor is less than 0.0001% by weight, anti-aging effect cannot be expected, and if it exceeds 20.0% by weight, the increase in the effect due to increase in content is insignificant and difficulties arise in manufacturing cosmetic formulations. .
- the sake lees extract from Gosori liquor according to the present invention is a natural substance that is harmless to the human body and has almost no toxicity or side effects, so it can be safely used even for long-term use, and can be safely applied to cosmetic compositions containing it.
- the sake lees extract which is an active ingredient of the present invention, does not irritate the skin and has excellent human safety, but also has an effect of inhibiting cell aging caused by oxidative stress, promoting collagen synthesis, inhibiting elastase activity, inhibiting secretion of inflammatory substances, promoting sebum secretion, and It can be usefully used as an anti-aging cosmetic composition that effectively improves skin aging by simultaneously having a whitening effect.
- Figure 1 is a diagram showing the cell senescence inhibitory effect of sake lees extract when oxidative stress is induced in normal human fibroblasts according to an embodiment of the present invention.
- Figure 2 is a diagram showing the collagen synthesis promoting effect of sake lees extract in normal human fibroblasts according to an embodiment of the present invention.
- Figure 3 is a diagram showing the elastase activity inhibitory effect of sake lees extract according to an embodiment of the present invention.
- Figure 4 is a diagram showing the inhibitory effect of the sake lees extract on the secretion of inflammatory substances when an inflammatory response is induced in mouse macrophages according to an embodiment of the present invention.
- Figure 5 is a diagram showing the effect of promoting sebum secretion after treating human sebum cells with sake lees extract according to an embodiment of the present invention.
- Figure 6 is a diagram showing the whitening effect of sake lees extract on human melanocytes according to an embodiment of the present invention.
- Example 2 Confirmation of the inhibitory effect of cellular senescence induced by oxidative stress in human fibroblasts
- HDFs Human dermal fibroblasts
- sake lees extract reduced the increased SA- ⁇ -gal activity caused by hydrogen peroxide treatment in human fibroblasts. From this, it was found that sake lees extract has an excellent effect of suppressing cellular aging caused by oxidative stress in human fibroblasts in a concentration-dependent manner.
- the amount of collagen synthesis in the sample prepared above was determined by measuring procollagen type I C-peptide (PICP, Type I C-peptide) using TAKARA's collagen measurement kit (MK101, Procollagen Type I C-peptide EIA kit). The amount was measured. The results are shown in Figure 2.
- Mouse macrophages (RAW264.7, macrophage) were inoculated at 2 ⁇ 10 5 per well in a 24-well plate containing RPMI medium supplemented with 10% FBS (fetal bovine serum), and then incubated in a 5% concentration CO 2 incubator. Cultured for 24 hours at 37°C. Afterwards, the test substance was dissolved in RPMI medium supplemented with 2% FBS, pretreated for 2 hours, and then LPS (Lipopolysaccharide 100 ng/mL), which can induce an inflammatory response, was treated in each well.
- FBS fetal bovine serum
- sake lees extract reduced the increased nitrite secretion due to LPS treatment in mouse macrophages. From this, it was found that sake lees extract was effective in suppressing the secretion of inflammatory substances caused by inducing an inflammatory response in mouse macrophages.
- the cells were stained with Nile red for 15 minutes at room temperature, and then the nuclei were stained with Hoechst 33342 to confirm the total number of cells, and the degree of sebum secretion was observed under a fluorescence microscope. Micrographs were analyzed with ImageJ, and the results are shown in Figure 5.
- Example 7 Confirmation of whitening effect in human melanocytes
- Example 8 Experiment to confirm the safety of sake lees extract on human skin
- An external skin preparation containing 1% of the sake lees extract of Example 1 was prepared with the ingredient contents shown in Table 1 below.
- an external skin agent purified water, glycerin, and butylene glycol were mixed and dissolved at 70°C (aqueous part), and the remaining ingredients except the above three ingredients and trimethanolamine were dissolved at 70°C (oil part).
- the oil part was added to the water part and stirred with a homomixer (Tokushu Kika, Japan) for primary emulsification, and trimethanolamine was finally added thereto. After removing the bubbles generated in the mixed solution, it was cooled to room temperature to prepare an external skin preparation.
- control group test group Purified water 72 71 glycerin 8.0 8.0 Butylene glycol 4.0 4.0 Gosori Sake Sake Lid Extract 0 1.0 Caprylic Capri Triglyceride 8.0 8.0 squalane 5.0 5.0 Cetearyl Glucuside 1.5 1.5 Sorbitan Stearate 0.4 0.4 cetearyl alcohol 1.0 1.0 Trimethanolamine 0.1 0.1 total weight 100 100
- test matter Number of subjects who responded average Skin irritation index 30 minutes later 24 hours later One 2 3 4
- a softening lotion containing Gosori liquor sake lees extract as an active ingredient was prepared according to a conventional method.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
La présente invention concerne une composition antivieillissement contenant un extrait de lie de vin de Gosori. L'extrait de la lie de vin de Gosori peut être avantageusement utilisé en tant que produit cosmétique, car il présente non seulement les effets d'inhibition du vieillissement cellulaire provoqué par le stress oxydatif, de promotion de la synthèse du collagène, de suppression de l'activité de l'élastase, d'inhibition de la sécrétion de substance inflammatoire, de la stimulation de la production de sébum, et de la fourniture d'un blanchiment de la peau simultanément, permettant ainsi une prévention et un soulagement efficaces du vieillissement de la peau, mais est également exempt d'irritation cutanée et présente une excellente sécurité pour le corps humain.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2022-0083698 | 2022-07-07 | ||
KR1020220083698A KR20240006879A (ko) | 2022-07-07 | 2022-07-07 | 고소리술 술지게미 추출물을 포함하는 항노화용 조성물 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024010355A1 true WO2024010355A1 (fr) | 2024-01-11 |
Family
ID=89453730
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2023/009485 WO2024010355A1 (fr) | 2022-07-07 | 2023-07-05 | Composition antivieillissement contenant un extrait de lie de vin de gosori |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR20240006879A (fr) |
WO (1) | WO2024010355A1 (fr) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05310590A (ja) * | 1992-05-15 | 1993-11-22 | Soken Kk | 活性酸素消去剤 |
JP2015232072A (ja) * | 2014-06-09 | 2015-12-24 | 共栄化学工業株式会社 | 化粧料 |
JP2019024360A (ja) * | 2017-07-27 | 2019-02-21 | 株式会社車多酒造 | エチル−α−D−グルコシドの製造方法及びその利用 |
KR20190048564A (ko) * | 2017-10-31 | 2019-05-09 | 에스케이바이오랜드 주식회사 | 용암해수를 이용하여 발효한 오메기주의 농축물을 포함하는 피부의 주름개선, 탄력개선 또는 보습용 화장료 조성물 |
KR20220086400A (ko) * | 2020-12-16 | 2022-06-23 | 정회철 | 이화주 부산물을 유효성분으로 포함하는 피부 미백 또는 재생용 화장료 조성물 |
-
2022
- 2022-07-07 KR KR1020220083698A patent/KR20240006879A/ko unknown
-
2023
- 2023-07-05 WO PCT/KR2023/009485 patent/WO2024010355A1/fr unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05310590A (ja) * | 1992-05-15 | 1993-11-22 | Soken Kk | 活性酸素消去剤 |
JP2015232072A (ja) * | 2014-06-09 | 2015-12-24 | 共栄化学工業株式会社 | 化粧料 |
JP2019024360A (ja) * | 2017-07-27 | 2019-02-21 | 株式会社車多酒造 | エチル−α−D−グルコシドの製造方法及びその利用 |
KR20190048564A (ko) * | 2017-10-31 | 2019-05-09 | 에스케이바이오랜드 주식회사 | 용암해수를 이용하여 발효한 오메기주의 농축물을 포함하는 피부의 주름개선, 탄력개선 또는 보습용 화장료 조성물 |
KR20220086400A (ko) * | 2020-12-16 | 2022-06-23 | 정회철 | 이화주 부산물을 유효성분으로 포함하는 피부 미백 또는 재생용 화장료 조성물 |
Also Published As
Publication number | Publication date |
---|---|
KR20240006879A (ko) | 2024-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2013027984A2 (fr) | Composition cosmétique contenant un composant de thé vert | |
KR101393007B1 (ko) | 람부탄 및 리치 추출물을 유효성분으로 함유하는 피부노화방지용 및 피부주름 개선용 화장료 조성물 | |
KR101600957B1 (ko) | 백화사설초, 대황, 닥나무 추출물을 함유하는 미백용 피부외용제 조성물 | |
KR102349786B1 (ko) | 주름 개선 및 미백용 화장료 조성물 | |
JP3226700B2 (ja) | 美白剤および皮膚外用剤 | |
KR101853743B1 (ko) | 음나무 추출물을 함유하는 피부 외용제 조성물 | |
KR101779523B1 (ko) | 플라보노이드 유도체를 함유하는 화장료 조성물 | |
KR102373899B1 (ko) | 피부의 주름 개선, 미백, 세포 재생, 상처 치유에 유효한 복합 천연물 추출물을 활성성분으로 함유하는 다 기능성 화장품 조성물 | |
WO2017217695A1 (fr) | Composition comprenant l'alpha-garcinia mangostana, le bêta-garcinia mangostana, le gamma-garcinia mangostana, ou le composé gartanin utilisé comme ingrédient efficace pour atténuer les rides de la peau ou pour hydrater la peau | |
JP4063822B2 (ja) | 皮膚しわ改善及び皮膚美白の二重機能性化粧料組成物。 | |
KR101418986B1 (ko) | 콜라겐 합성 촉진용 조성물 및 이를 포함하는 화장품 | |
WO2012173382A2 (fr) | Composition à usage externe pour l'épiderme, contenant du tanshinone ii a en tant que principe actif | |
KR20170055172A (ko) | 중머리풀 추출물을 유효성분으로 함유하는 화장료 조성물 | |
WO2024010355A1 (fr) | Composition antivieillissement contenant un extrait de lie de vin de gosori | |
WO2010058986A2 (fr) | Composition cosmétique contenant des extraits d'adenophora triphylla var. japonica hara, d'angelica tenuissima et de plantes médicinales | |
KR20140081138A (ko) | 우장지버섯 자실체 추출물 또는 우장지버섯 균사체 추출물을 함유하는 피부 외용제 조성물 | |
KR101402193B1 (ko) | 아위버섯 자실체 추출물 또는 아위버섯 균사체 추출물 또는 아위버섯 균사체 배양액을 함유하는 피부 미백용 화장료 조성물 | |
KR20210060801A (ko) | 식물 복합 발효물을 유효성분으로 포함하는 항노화 화장료 조성물 | |
KR100468434B1 (ko) | 비타민 c 또는 그 유도체 및 빈랑자 추출물을 함유하는피부 노화 방지용 화장료 조성물 | |
KR101418979B1 (ko) | 콜라겐 형성 촉진용 조성물 및 그를 이용한 화장품 | |
KR20160003918A (ko) | 한약재 추출물을 포함하는 피부 탄력 증진 또는 주름 개선용 화장료 조성물 | |
KR101580965B1 (ko) | 삼색도장버섯 자실체 추출물 또는 삼색도장버섯 균사체 추출물 또는 삼색도장버섯 균사체의 배양액을 함유하는 화장료 조성물 및 피부외용제 조성물 | |
KR20140081137A (ko) | 곰보버섯 자실체 추출물 또는 곰보버섯 균사체 추출물을 함유하는 피부 외용제 조성물 | |
WO2012173383A2 (fr) | Composition à usage externe pour l'épiderme, contenant en tant que principe actif du cryptotanshinone | |
KR101458496B1 (ko) | 아위버섯 자실체 추출물 또는 아위버섯 균사체 추출물 또는 아위버섯 균사체 배양액을 함유하는 항염용 피부 외용제 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23835821 Country of ref document: EP Kind code of ref document: A1 |